Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Peng

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|January 6, 2026
QSAR Prediction of BBB Permeability Based on Machine Learning upon PETBD: A Novel Data Set of PET TracersQing Su, Zhilong Ye, Chunyan Han, et al.
Cancer Research|August 15, 2008
BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repressionDorothea Douglas, Jessie Hao-Ru Hsu, Long Hung, et al.
AIDS (London, England)|June 18, 2009
Continuous antiretroviral therapy decreases bone mineral densityBirgit Grund, Grace Peng, Cynthia L Gibert, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Lancet (London, England)|December 19, 2006
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trialRodger D MacArthur, Richard M Novak, Grace Peng, et al.
HIV Clinical Trials|November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategiesMichael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapyRichard M Novak, Li Chen, Rodger D MacArthur, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|January 6, 2026
QSAR Prediction of BBB Permeability Based on Machine Learning upon PETBD: A Novel Data Set of PET TracersQing Su, Zhilong Ye, Chunyan Han, et al.
Cancer Research|August 15, 2008
BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repressionDorothea Douglas, Jessie Hao-Ru Hsu, Long Hung, et al.
AIDS (London, England)|June 18, 2009
Continuous antiretroviral therapy decreases bone mineral densityBirgit Grund, Grace Peng, Cynthia L Gibert, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Lancet (London, England)|December 19, 2006
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trialRodger D MacArthur, Richard M Novak, Grace Peng, et al.
HIV Clinical Trials|November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategiesMichael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapyRichard M Novak, Li Chen, Rodger D MacArthur, et al.
Pageof 3